ICU查房清单对患者结局的影响:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE、Embase、CINAHL、Cochrane Library和Google Scholar(自建库至2024年5月10日),纳入比较使用查房清单与不使用清单的队列研究、病例对照研究和随机对照试验。共纳入30项研究(包括超过32,000例患者)。使用ICU查房清单与住院死亡率降低相关(RR 0.80;95%CI 0.70-0.92;12项观察性研究;17,269例患者;I2=48%;证据确定性极低),并与ICU死亡率(8项观察性研究,p=0.006)、30天死亡率(2项观察性研究,p<0.001)、住院时间(11项观察性研究,p=0.02)、导管相关尿路感染(6项观察性研究,p=0.01)和中心线相关血流感染(6项观察性研究,p=0.02)降低相关。作者认为查房清单可能改善住院死亡率及其他重要患者相关结局,但需要精心设计的随机研究来提高证据确定性并确定清单应包含哪些要素。
要点
- 使用ICU查房清单与住院死亡率降低相关(RR 0.80;95%CI 0.70-0.92;12项观察性研究;17,269例患者;I2=48%;证据确定性极低)。
- 使用ICU查房清单与ICU死亡率(8项观察性研究,p=0.006)和30天死亡率(2项观察性研究,p<0.001)降低相关。
- 使用ICU查房清单与住院时间缩短(11项观察性研究,p=0.02)、导管相关尿路感染减少(6项观察性研究,p=0.01)和中心线相关血流感染减少(6项观察性研究,p=0.02)相关。
- 其他患者相关结局在使用ICU查房清单后无显著差异;医护人员对清单的看法总体积极。
- 作者认为查房清单可能改善住院死亡率及其他重要患者相关结局,但需要精心设计的随机研究来提高证据确定性并确定清单应包含哪些要素。
适用人群与场景
- 纳入比较使用查房清单与不使用清单的队列研究、病例对照研究和随机对照试验,研究对象为入住ICU的患者。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,检索MEDLINE、Embase、CINAHL、Cochrane Library和Google Scholar(自建库至2024年5月10日),纳入队列研究、病例对照研究和随机对照试验,共纳入30项研究(包括超过32,000例患者)。
- 主要结局:使用ICU查房清单与住院死亡率降低相关(RR 0.80;95%CI 0.70-0.92;12项观察性研究;17,269例患者;I2=48%;证据确定性极低)。
- 次要结局:使用ICU查房清单与ICU死亡率降低相关(8项观察性研究,p=0.006);与30天死亡率降低相关(2项观察性研究,p<0.001);与住院时间缩短相关(11项观察性研究,p=0.02);与导管相关尿路感染减少相关(6项观察性研究,p=0.01);与中心线相关血流感染减少相关(6项观察性研究,p=0.02)。
- 其他患者相关结局在使用ICU查房清单后无显著差异。
- 医护人员对清单的看法总体积极。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,采用逆方差随机效应模型合并估计值,使用推荐分级的评估、制定与评价(GRADE)评估证据确定性。
- 住院死亡率结局的证据确定性为极低。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,使用ICU查房清单可能改善住院死亡率及其他重要患者相关结局,但需要精心设计的随机研究来提高证据确定性并确定清单应包含哪些要素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the effectiveness of ICU rounding checklists on outcomes.
DATA SOURCES: Five electronic databases (MEDLINE, Embase, CINAHL, Cochrane Library, and Google Scholar) were searched from inception to May 10, 2024.
STUDY SELECTION: Cohort studies, case-control studies, and randomized controlled trials comparing the use of rounding checklists to no checklists were included. Other article types were excluded.
DATA EXTRACTION: The primary outcome was in-hospital mortality. Secondary outcomes included ICU and 30-day mortality; hospital and ICU length of stay (LOS); duration of mechanical ventilation; and frequency of catheter-associated urinary tract infections, central line-associated bloodstream infections (CLABSI), and ventilator-associated pneumonia. Additional outcomes included healthcare provider perceptions of checklists.
DATA SYNTHESIS: Pooled estimates were obtained using an inverse-variance random-effects meta-analysis model. Certainty of evidence was evaluated using Grading of Recommendations Assessment, Development, and Evaluation. There were 30 included studies (including > 32,000 patients) in the review. Using an ICU rounding checklist was associated with reduced in-hospital mortality (risk ratio [RR] 0.80; 95% CI, 0.70-0.92; 12 observational studies; 17,269 patients; I2 = 48%; very low certainty of evidence). The use of an ICU rounding checklist was also associated with reduced ICU mortality (8 observational studies, p = 0.006), 30-day mortality (2 observational studies, p < 0.001), hospital LOS (11 observational studies, p = 0.02), catheter-associated urinary tract infections (CAUTI) (6 observational studies, p = 0.01), and CLABSI (6 observational studies, p = 0.02). Otherwise, there were no significant differences with using ICU rounding checklists on other patient-related outcomes. Healthcare providers' perceptions of checklists were generally positive.
CONCLUSIONS: The use of an ICU rounding checklist may improve in-hospital mortality, as well as other important patient-related outcomes. However, well-designed randomized studies are necessary to increase the certainty of evidence and determine which elements should be included in an ICU rounding checklist.
参考来源
- MacKinnon KM, Seshadri S, Mailman JF, et al. Impact of Rounding Checklists on the Outcomes of Patients Admitted to ICUs: A Systematic Review and Meta-Analysis. Crit Care Explor. 2024. PMID: 39162653. doi:10.1097/CCE.0000000000001140
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。